|
[1]
|
King, M., Nazareth, I., Levy, G., Walker, C., Morris, R., Weich, S., Bellon-Saameno, J.A., Moreno, B., Svab, I., Rotar, D., Rifel, J., Maaroos, H.I., Aluoja, A., Kalda, R., Neeleman, J., Geerlings, M.I., Xavier, M., de Almeida, M.C., Correa, B. and Torres-Gonzalez, F. (2008) Prevalence of common mental disorders in general practice attendees across Europe. The British Journal of Psychiatry, 192, 362-367. doi:10.1192/bjp.bp.107.039966
|
|
[2]
|
NICE (2009) Depression: The treatment and management of depression in adults (Clinical Guideline 90). National Institute for Health and Clinical Excellence, London.
|
|
[3]
|
Claxton, A.J., Li, Z. and McKendrick, J. (2000) Selective serotonin reuptake inhibitor treatment in the UK: Risk of relapse or recurrence of depression. The British Journal of Psychiatry, 177, 163-168. doi:10.1192/bjp.177.2.163
|
|
[4]
|
Judd, L.L., Paulus, M.J., Schettler, P.J., Akiskal, H.S., Endicott, J., Leon, A.C., Maser, J.D., Mueller, T., Solomon, D.A. and Keller, M.B. (2000) Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry, 157, 1501-1504. doi:10.1176/appi.ajp.157.9.1501
|
|
[5]
|
Judd, L.L., Akiskal, H.S., Maser, J.D., Zeller, P.J., Endicott, J., Coryell, W., Paulus, M.P., Kunovac, J.L., Leon, A.C., Mueller, T.I., Rice, J.A. and Keller, M.B. (1998) Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders, 50, 97-108.
doi:10.1016/S0165-0327(98)00138-4
|
|
[6]
|
Mitchell, A.J. and Selmes, T. (2007) Why don’t patients take their medicine? Reasons and solutions in psychiatry. Advances in Psychiatric Treatment, 13, 336-346.
doi:10.1192/apt.bp.106.003194
|
|
[7]
|
Fortney, J.C., Pyne, J.M., Edlund, M.J., Stecker, T., Mittal, D., Robinson, D.E. and Henderson, K.L. (2011) Reasons for antidepressant nonadherence among veterans treated in primary care clinics. Journal of Clinical Psychiatry, 72, 827-834. doi:10.4088/JCP.09m05528blu
|
|
[8]
|
Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D., Niederehe, G., Thase, M.E., Lavori, P.W., Lebowitz, B.D., McGrath, P.J., Rosenbaum, J.F., Sackeim, H.A., Kupfer, D.J., Luther, J. and Fava, M. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905-1917. doi:10.1176/appi.ajp.163.11.1905
|
|
[9]
|
Anderson, H.D., Pace, W.D., Libby, A.M., West, D.R. and Valuck, R.J. (2012) Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: A retrospective US claims study. Clinical Therapeutics, 34, 113-123.
doi:10.1016/j.clinthera.2011.11.024
|
|
[10]
|
Kikuchi, T., Suzuki, T., Uchida, H., Watanabe, K. and Kashima, H. (2011) Subjective recognition of adverse events with antidepressant in people with depression: A prospective study. Journal of Affective Disorders, 135, 347-353. doi:10.1016/j.jad.2011.07.011
|
|
[11]
|
Moore, M., Yuen, H.M., Dunn, N., Mullee, M.A., Maskell, J. and Kendrick, T. (2009) Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. British Medical Journal, 339, b3999. doi:10.1136/bmj.b3999
|
|
[12]
|
Wade, A.G., Saragoussi, D., Despiegel, N., Francois, C., Guelfucci, F. and Toumi, M. (2010) Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK. Current Medical Research & Opinion, 26, 1161-1170.
doi:10.1185/03007991003738519
|
|
[13]
|
Kurd, S.K., Troxel, A.B., Crits-Christoph, P. and Gelfand, J.M. (2010) The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Archives of Dermatology, 146, 891-895.
doi:10.1001/archdermatol.2010.186
|
|
[14]
|
Becker, C., Brobert, G.P., Johansson, S., Jick, S.S. and Meier, C.R. (2011) Risk of incident depression in patients with Parkinson disease in the UK. European Journal of Neurology, 18, 448-453.
doi:10.1111/j.1468-1331.2010.03176.x
|
|
[15]
|
Lewis, J.D., Bilker, W.B., Weinstein, R.B. and Strom, B.L. (2005) The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiology and Drug Safety, 14, 443-451. doi:10.1002/pds.1115
|
|
[16]
|
Chisholm, J. (1990) The Read clinical classification. British Medical Journal, 300, 1092.
doi:10.1136/bmj.300.6732.1092
|
|
[17]
|
Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-613.
doi:10.1046/j.1525-1497.2001.016009606.x
|
|
[18]
|
Zigmond, A.S. and Snaith, R.P. (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.
doi:10.1111/j.1600-0447.1983.tb09716.x
|
|
[19]
|
Beck, A.T., Steer, R.A. and Brown, G.K. (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio.
|
|
[20]
|
Gilbody, S., Richards, D., Brealey, S. and Hewitt, C. (2007) Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): A diagnostic meta-analysis. Journal of General Internal Medicine, 22, 1596-1602. doi:10.1007/s11606-007-0333-y
|
|
[21]
|
Elliott, W.J., Plauschinat, C.A., Skrepnek, G.H. and Gause, D. (2007) Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. The Journal of the American Board of Family Medicine, 20, 72-80.
doi:10.3122/jabfm.2007.01.060094
|
|
[22]
|
Charlson, M.E., Pompei, P., Ales, K.L. and MacKenzie, C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383.
doi:10.1016/0021-9681(87)90171-8
|
|
[23]
|
Khan, N.F., Perera, R., Harper, S. and Rose, P.W. (2010) Adaptation and validation of the Charlson Index for Read/ OXMIS coded databases. BMC Family Practice, 11, 1.
doi:10.1186/1471-2296-11-1
|
|
[24]
|
Warner-Schmidt, J.L., Vanover, K.E., Chen, E.Y., Marshall, J.J. and Greengard, P. (2011) Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by anti-inflammatory drugs in mice and humans. Proceedings of the National Academy of Sciences of the United States of America, 108, 9262-9267.
doi:10.1073/pnas.1104836108
|
|
[25]
|
Lee, Y.M. and Lee, K.U. (2011) Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression. Psychiatry and Clinical Neurosciences, 65, 630-637.
doi:10.1111/j.1440-1819.2011.02275.x
|
|
[26]
|
Olfson, M., Marcus, S.C., Tedeschi, M. and Wan, G.J. (2006) Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry, 163, 101-108. doi:10.1176/appi.ajp.163.1.101
|
|
[27]
|
Simon, G.E., Von Korff, M., Wagner, E.H. and Barlow, W. (1993) Patterns of antidepressant use in community practice. General Hospital Psychiatry, 15, 399-408.
doi:10.1016/0163-8343(93)90009-D
|
|
[28]
|
Hansen, D.G., Vach, W., Rosholm, J.U., Sondergaard, J., Gram, L.F. and Kragstrup, J. (2004) Early discontinuation of antidepressants in general practice: Association with patient and prescriber characteristics. The Journal of Family Practice, 21, 623-629.
doi:10.1093/fampra/cmh608
|
|
[29]
|
Rait, G., Walters, K., Griffin, M., Buszewicz, M., Petersen, I. and Nazareth, I. (2009) Recent trends in the incidence of recorded depression in primary care. The British Journal of Psychiatry, 195, 520-524.
doi:10.1192/bjp.bp.108.058636
|
|
[30]
|
Demyttenaere, K., Enzlin, P., Dewe, W., Boulanger, B., De, B.J., De, T.W. and Mesters, P. (2001) Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry, 62 Suppl 22, 30-33.
|
|
[31]
|
Lin, E.H., Von, K.M., Katon, W., Bush, T., Simon, G.E., Walker, E. and Robinson, P. (1995) The role of the primary care physician in patients’ adherence to antidepressant therapy. Medical Care, 33, 67-74.
doi:10.1097/00005650-199501000-00006
|
|
[32]
|
Lewis, E., Marcus, S.C., Olfson, M., Druss, B.G. and Pincus, H.A. (2004) Patients’ early discontinuation of antidepressant prescriptions. Psychiatric Services, 55, 494.
doi:10.1176/appi.ps.55.5.494
|
|
[33]
|
Serna, M.C., Cruz, I., Real, J., Gasco, E. and Galvan, L. (2010) Duration and adherence of antidepressant treatment (2003-2007) based on prescription database. European Psychiatry, 25, 206-213.
doi:10.1016/j.eurpsy.2009.07.012
|
|
[34]
|
Mabotuwana, T., Warren, J., Orr, M., Kenealy, T. and Harrison, J. (2011) Using primary care prescribing data to improve GP awareness of antidepressant adherence issues. Informatics in Primary Care, 19, 7-15.
|
|
[35]
|
Aikens, J.E., Kroenke, K., Swindle, R.W. and Eckert, G.J. (2005) Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. General Hospital Psychiatry, 27, 229-236.
doi:10.1016/j.genhosppsych.2005.04.001
|
|
[36]
|
Meijer, W.E., Heerdink, E.R., Leufkens, H.G., Herings, R.M., Egberts, A.C. and Nolen, W.A. (2004) Incidence and determinants of long-term use of antidepressants. European Journal of Clinical Pharmacology, 60, 57-61.
doi:10.1007/s00228-004-0726-3
|
|
[37]
|
Horne, R. (1999) Patients’ beliefs about treatment: The hidden determinant of treatment outcome? Journal of Psychosomatic Research, 47, 491-495.
doi:10.1016/S0022-3999(99)00058-6
|
|
[38]
|
Aikens, J.E., Nease, D.E., Jr. and Klinkman, M.S. (2008) Explaining patients’ beliefs about the necessity and harmfulness of antidepressants. The Annals of Family Medicine, 6, 23-29. doi:10.1370/afm.759
|
|
[39]
|
Hirschfeld, R.M. (2003) Long-term side effects of SSRIs: Sexual dysfunction and weight gain. Journal of Clinical Psychiatry, 64 Suppl 18, 20-24.
|
|
[40]
|
Fakhoury, W.K., Wright, D. and Wallace, M. (2001) Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology, 16, 153-162.
doi:10.1097/00004850-200105000-00004
|
|
[41]
|
Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J. and Johnson, B.T. (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLOS Medicine, 5, e45. doi:10.1371/journal.pmed.0050045
|
|
[42]
|
Kirsch, I. (2009) Antidepressants and the placebo response. Epidemiologia e psichiatria sociale, 18, 318-322.
|
|
[43]
|
Thase, M.E., Ferguson, J.M., Lydiard, R.B. and Wilcox, C.S. (2002) Citalopram treatment of paroxetine-intolerant depressed patients. Depression and Anxiety, 16, 128-133.
doi:10.1002/da.10055
|
|
[44]
|
Rambelomanana, S., Depont, F., Forest, K., Hebert, G., Blazejewski, S., Fourrier-Reglat, A., Molimard, M. and Moore, N. (2006) Antidepressants: General practitioners’ opinions and clinical practice. Acta Psychiatrica Scandinavica, 113, 460-467.
doi:10.1111/j.1600-0447.2006.00793.x
|
|
[45]
|
Edwards, J.G. and Anderson, I. (1999) Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs, 57, 507-533.
doi:10.2165/00003495-199957040-00005
|